Article information
Full text is only aviable in PDF
BIBLIOGRAPHIE
[1.]
Anonymous.
International guidelines for the selection of lung transplant candidates.
Am J Respir Crit Care Med, 158 (1998), pp. 335-339
[2.]
A.C. Anyanwu, A. Mcguire, C.A. Rogers, M. Murday.
Assessment of quality of life in lung transplantation using a simple generic tool.
Thorax, 56 (2001), pp. 218-222
[3.]
N. Caine, L.D. Sharples, C. Dennis, T.W. Higenbottam, J. Wallwork.
Measurement of health-related quality of life before and after heart lung transplantation.
J Heart Lung Transplant, 15 (1996), pp. 1047-1058
[4.]
C.C. Chaparro, M. Scavuzzo, T. Winton, S. Keshavjee, S. Kesten.
Status of lung transplant recipients surviving beyong five years.
J Heart Lung Transplant, 16 (1997), pp. 511-516
[5.]
S.C. Charman, L.D. Sharples, K.D. Mcneil, J. Wallwork.
Assessment of survival benefit after lung transplantation by patients diagnosis.
J Heart Lung Transplant, 21 (2002), pp. 226-232
[6.]
L. Cohen, C. Littlefield, P. Kelly, J. Maurer, S. Abbey.
Predictors of quality of life and adjustement after lung transplantation.
Chest, 113 (1998), pp. 633-644
[7.]
J. Demeester, J.M.A. Smits, G.G. Persun, A. Haverich.
Listing for lung transplantation: Life expectancy and transplant effect, stratified by type of end stage lung disease, the Eurotransplant experience.
J Heart Lung Transplant, 20 (2001), pp. 518-524
[8.]
J.I.D. Hosenpud, L.E. Bennett, B.I.V.I. Keck, M.M. Boucek, R.J. Novick.
The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Report 2001.
J Heart Lung Transplant, 20 (2001), pp. 805-815
[9.]
J. Hosenpund, L.E. Bennett, B.M. Keck, E.B. Edwards, R.J. Novick.
Effect of diagnosis on survival benefit of lung transplantation for end stage lung disease.
Lancet, 351 (1998), pp. 24-27
[10.]
R. KÜSS, P. Bourget.
Une histoire illustrée de Ia greffe d’organe, Laboratoire Sandoz, (1992), pp. 102-118
[11.]
D.M. Lanuza, C. Lefaiver, M. McCabe, G.A. Farcas, E. Garrity.
Prospective study of functional status and quality of life before and after lung transplantation.
Chest, 118 (2000), pp. 115-122
[12.]
G.I. Snell, M. Rabinov, A. Griffiths, T. Williams, A. Ugoni, R. Salamonsson, et al.
Pulmonary allograft ischemic time: an important predictor of survival after lung transplantation.
J Heart Lung Transplant, 15 (1996), pp. 160-168
[13.]
G.I. Snell, M. Richardson, A.P. Griffiths, T.J. Williams, D.S. Esmore.
Coronary artery disease in potential lung transplantation recipients>50 years old. The role of coronary intervention.
Chest, 116 (1999), pp. 874-879
[14.]
S. Sundaresan, Mohanakumar T., M.A. Smith, E.P. Trulock, J. Lynch, D. Phelan, et al.
HLA A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchilitis obliterans syndrome.
Transplantation, 65 (1998), pp. 648-653
[15.]
D.E.N. Van, J.W.K. Berg, A. Geertsma, W.I.M. Van Der Bij, G.H. Koëter, K.W. De Boer, D.S. Postma, E.M. Ten Vergert.
Bronchiolitis obliterans syndrome after lung transplantation and health related quality of life.
Am J Respir Crit Care Med, 161 (2000), pp. 1937-1941
Copyright © 2002. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options